The Patient Impact in Drug Development and Value Demonstration with Len Lichtenfeld, MD, MACP

Now, more than ever, the patient voice is being heard by the pharmaceutical industry.  In this episode, Peg Crowley-Nowick, PhD, MBA, President of Medical Affairs Consulting at Lumanity, and Len Lichtenfeld, MD, MACP meet to discuss the ways patients are providing advisement in drug development and valuation.  After hearing about Len's extensive experience, they delve into the new regulatory changes coming to pharma and biotech that will require the patient experience to be taken into consideration during the drug development process. They conclude by discussing how the patient experience is having an impact on the valuation of new drugs.